![Hardean Achneck](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hardean Achneck
Corporate Officer/Principal chez
The European Society of Cardiology
Profil
Hardean E.
Achneck is currently a Member at American Heart Association, Inc., The International Society of Thrombosis & Hemostasis, The European Society of Cardiology, and American Society of Gene & Cell Therapy.
Former positions include Vice President & Head-Medical Development at Dicerna Pharmaceuticals, Inc. from 2019 to 2022; Assistant Professor-Surgery & Pathology at Duke University School of Medicine from 2010 to 2014; Assistant Professor-Cardiovascular at Duke Nus Medical School; Chief Medical Officer at Hemostemix, Inc. in 2016; Senior Vice President & Head-Clinical Development at Pliant Therapeutics, Inc.; and Chief Medical Officer & Executive Vice President at Aligos Therapeutics, Inc. from 2024 to 2026.
Education includes undergraduate studies at Yale University and a doctorate from Yale School of Medicine.
Postes actifs de Hardean Achneck
| Sociétés | Poste | Début |
|---|---|---|
The European Society of Cardiology | Corporate Officer/Principal | - |
The International Society of Thrombosis & Hemostasis | Corporate Officer/Principal | - |
American Society of Gene & Cell Therapy
 American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services Operates as medical and professional organization that represents researchers and scientists devoted to the discovery | Corporate Officer/Principal | - |
American Heart Association, Inc.
 American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services Operates a voluntary health organization | Corporate Officer/Principal | - |
Anciens postes connus de Hardean Achneck
| Sociétés | Poste | Fin |
|---|---|---|
| ALIGOS THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 21/01/2026 |
| DICERNA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/06/2022 |
| HEMOSTEMIX INC. | Directeur des opérations | - |
Duke University School of Medicine
 Duke University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2014 |
Formation de Hardean Achneck
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
84
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Dicerna Pharmaceuticals, Inc.
 Dicerna Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that focuses on discovering, developing and commercializing medicines for chronic liver diseases | Health Technology |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Heart Association, Inc.
American Heart Association, Inc. Miscellaneous Commercial ServicesCommercial Services Operates a voluntary health organization | Commercial Services |
The International Society of Thrombosis & Hemostasis | |
The European Society of Cardiology | |
Hemostemix, Inc.
 Hemostemix, Inc. BiotechnologyHealth Technology Develops, manufactures and commercializes blood-derived stem cell therapies for medical conditions | Health Technology |
Yale School of Medicine
 Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Duke University School of Medicine
Duke University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Society of Gene & Cell Therapy
American Society of Gene & Cell Therapy Miscellaneous Commercial ServicesCommercial Services Operates as medical and professional organization that represents researchers and scientists devoted to the discovery | Commercial Services |
Pliant Therapeutics, Inc.
 Pliant Therapeutics, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company focuses on discovering and developing novel therapies for the treatment of fibrosis | Health Technology |
Aligos Therapeutics, Inc.
 Aligos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted, curative therapies for hepatologic diseases and viral infections | Health Technology |
